CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,035 enrolled
Drug / intervention
Exposure SARS-CoV-2 Infectionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05249868
NCT05249868N/ACompleted

Multicentre Study on the Impact of the SARS-CoV-2 Pandemic on the Health Status of People Aged 75 and Over and Their Caregivers (CUIDAMOS+75 Project)

Gerencia de Atención Primaria, Madrid·observational·Posted Feb 22, 2022·Updated Sep 3, 2025

In Brief

An observational study evaluating Exposure SARS-CoV-2 Infection for Aging and 4 related conditions. Completed, enrolled 1,035 participants across 2 sites.

Detailed Summary

The measures to control the transmissibility of the Covid-19 pandemic have changed the daily routines of the population, increasing sedentary lifestyles, decreasing outdoor physical activity and limiting contact with neighbors, family and friends. This could be having negative consequences for the health of vulnerable people. The investigators want to know how this situation has affected the health of people aged 75 years or older and their caregivers and how the circumstances experienced may mark new care needs. To this end, will be analyzed clinical data, follow up people who have become ill with COVID-19 and those who have not, and interview groups of caregivers and patients to hear about the personal impact of the pandemic on them. This will allow us to explore what changes are needed in health care to achieve an improvement in the health and quality of life of this population. CUIDAMOS+75 seeks the commitment of the population and of the different people in charge of the health services from the very beginning.

Study Details

Timeline

N/ACompletedFinished
2023202420252026
First PostedFeb 22, 2022
Enrollment StartJun 1, 2022
Primary CompletionDec 1, 2024
Study CompletionJan 31, 2025
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 4.4 years ago

Interventions

Exposure SARS-CoV-2 Infectionother

The exposure variable is confirmed SARS-CoV-2 infection with diagnosis after 11 May 2020. Positive confirmatory test on nucleic acid amplification (rRT-PCR) or having had symptoms for \<5 days is positive on a PRAg test.